Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramipexole plus repetitive transcranial magnetic stimulation for aberrant motor behavior in dementia
RBR-9zmnvn6Phase 1Completed
- Sponsor
- Universidade Federal de Sergipe
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of pramipexole in Aberrant motor behavior (AMB) and Alzheimer's disease (AD) (3 arms), sponsored by Universidade Federal de Sergipe. Started Jun 2023; status: completed.
02
Drugs
pramipexole
03
Conditions
Aberrant motor behavior (AMB)Alzheimer's disease (AD)
Beyond the preview
Go deeper on RBR-9zmnvn6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-9zmnvn6.